REVA Medical, Inc. designs and manufactures medical devices. The Company offers drug-eluting bioresorbable coronary scaffolds for the treatment of cardiovascular diseases. REVA Medical serves customers worldwide.

Reva Receives Additional Interim Funding

REVA Receives Interim Funding and Amends License Agreement 21

Reva Receives Interim Funding And Amends License Agreement 21

Receipt of Interim Funding Commitment and Leadership Changes

Receipt Of Interim Funding Commitment And Leadership Changes

Reva Continues Suspension Of Trading

S&P DJI Announces March 2019 Quarterly Rebalance

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Reva Medical (RVA AU)

Reva Receives Additional Interim Funding

Reva Receives Interim Funding And Amends License Agreement 21

Receipt Of Interim Funding Commitment And Leadership Changes

Reva Continues Suspension Of Trading

S&P Dji Announces March 2019 Quarterly Rebalance

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)